Literature DB >> 20478944

Mechanisms and regulation of the gene-expression response to sepsis.

Timothy T Cornell1, James Wynn, Thomas P Shanley, Derek S Wheeler, Hector R Wong.   

Abstract

Sepsis is defined as the systemic inflammatory response of the human host that is triggered by an invading pathogen. Despite tremendous advances in both our knowledge of and treatment strategies for this syndrome, sepsis remains among the major causes of morbidity and mortality in children worldwide. Thus, we hypothesize that an improved mechanistic understanding obtained via basic and translational science will continue to identify novel therapeutic targets and approaches. As a result, given the central importance of the alterations in gene expression in regulating the human host's physiologic response to a pathogen, we review the complex factors-genetics, transcriptional expression, and epigenetics-that regulate unique gene-expression patterns in pediatric sepsis and septic shock. We anticipate that emerging data from genetic, genomic, and other translation studies in pediatric sepsis will advance our biological understanding of this response and undoubtedly identify targets for newer therapies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20478944      PMCID: PMC2892227          DOI: 10.1542/peds.2009-3274

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  87 in total

1.  TAT-BH4 and TAT-Bcl-xL peptides protect against sepsis-induced lymphocyte apoptosis in vivo.

Authors:  Richard S Hotchkiss; Kevin W McConnell; Kristin Bullok; Christopher G Davis; Katherine C Chang; Steven J Schwulst; Jeffrey C Dunne; Gunnar P H Dietz; Mathias Bähr; Jonathan E McDunn; Irene E Karl; Tracey H Wagner; J Perren Cobb; Craig M Coopersmith; David Piwnica-Worms
Journal:  J Immunol       Date:  2006-05-01       Impact factor: 5.422

2.  Meningococcal disease and polymorphism of FcgammaRIIa (CD32) in late complement component-deficient individuals.

Authors:  A E Platonov; E J Kuijper; I V Vershinina; G A Shipulin; N Westerdaal; C A Fijen; J G van de Winkel
Journal:  Clin Exp Immunol       Date:  1998-01       Impact factor: 4.330

Review 3.  Cytokine and cytokine receptor polymorphisms in infectious disease.

Authors:  S J van Deventer
Journal:  Intensive Care Med       Date:  2000       Impact factor: 17.440

4.  Variation within genes encoding interleukin-1 and the interleukin-1 receptor antagonist influence the severity of meningococcal disease.

Authors:  Robert C Read; Chris Cannings; Simone C Naylor; Janine M Timms; Ravi Maheswaran; Raymond Borrow; Edward B Kaczmarski; Gordon W Duff
Journal:  Ann Intern Med       Date:  2003-04-01       Impact factor: 25.391

5.  Interleukin-8 and CXCR1 receptor functional polymorphisms and susceptibility to acute pyelonephritis.

Authors:  Lina Artifoni; Susanna Negrisolo; Giovanni Montini; Pietro Zucchetta; Pier Paolo Molinari; Walburga Cassar; Roberta Destro; Franca Anglani; Waifro Rigamonti; Graziella Zacchello; Luisa Murer
Journal:  J Urol       Date:  2007-03       Impact factor: 7.450

Review 6.  Prevention of lymphocyte apoptosis--a potential treatment of sepsis?

Authors:  Richard S Hotchkiss; Craig M Coopersmith; Irene E Karl
Journal:  Clin Infect Dis       Date:  2005-11-15       Impact factor: 9.079

7.  Sepsis and septic shock: a history.

Authors:  Duane J Funk; Joseph E Parrillo; Anand Kumar
Journal:  Crit Care Clin       Date:  2009-01       Impact factor: 3.598

8.  Interleukin-8 as a stratification tool for interventional trials involving pediatric septic shock.

Authors:  Hector R Wong; Natalie Cvijanovich; Derek S Wheeler; Michael T Bigham; Marie Monaco; Kelli Odoms; William L Macias; Mark D Williams
Journal:  Am J Respir Crit Care Med       Date:  2008-05-29       Impact factor: 21.405

9.  Validating the genomic signature of pediatric septic shock.

Authors:  Natalie Cvijanovich; Thomas P Shanley; Richard Lin; Geoffrey L Allen; Neal J Thomas; Paul Checchia; Nick Anas; Robert J Freishtat; Marie Monaco; Kelli Odoms; Bhuvaneswari Sakthivel; Hector R Wong
Journal:  Physiol Genomics       Date:  2008-05-06       Impact factor: 3.107

10.  Interleukin-6 gene variants and the risk of sepsis development in children.

Authors:  Jaroslav Michalek; Petra Svetlikova; Michal Fedora; Michal Klimovic; Lenka Klapacova; Drahomira Bartosova; Hana Hrstkova; Jaroslav A Hubacek
Journal:  Hum Immunol       Date:  2007-07-16       Impact factor: 2.850

View more
  31 in total

Review 1.  Gene Expression Profiles in Children With Suspected Sepsis.

Authors:  Fran Balamuth; Elizabeth R Alpern; Mengyuan Kan; Maya Shumyatcher; Katie Hayes; Ebbing Lautenbach; Blanca E Himes
Journal:  Ann Emerg Med       Date:  2020-01-23       Impact factor: 5.721

Review 2.  Impact of cytomegalovirus load on host response to sepsis.

Authors:  Thomas Marandu; Michael Dombek; Charles H Cook
Journal:  Med Microbiol Immunol       Date:  2019-04-11       Impact factor: 3.402

3.  Bugs, genes, and the intensive care unit.

Authors:  Kerina Jane Denny; Jeffrey Lipman
Journal:  J Thorac Dis       Date:  2016-08       Impact factor: 2.895

4.  A Single-Center Review of Prescribing Trends and Outcomes of Corticosteroid Replacement Therapy in Critically Ill Children with Septic Shock.

Authors:  Scott T Benken; Tamara K Hutson; Rhonda L Gardiner; Derek S Wheeler
Journal:  Open Crit Care Med J       Date:  2010-01-01

5.  'Stalled' periocular necrotising fasciitis: early effective treatment or host genetic determinants?

Authors:  A Mutamba; D H Verity; G E Rose
Journal:  Eye (Lond)       Date:  2013-02-15       Impact factor: 3.775

Review 6.  Role of Zinc in Neonatal Sepsis.

Authors:  Newton Banupriya; Ballambattu Vishnu Bhat; Magadi Gopalakrishna Sridhar
Journal:  Indian J Pediatr       Date:  2021-04-24       Impact factor: 1.967

Review 7.  Cytokine storm and sepsis disease pathogenesis.

Authors:  Benjamin G Chousterman; Filip K Swirski; Georg F Weber
Journal:  Semin Immunopathol       Date:  2017-05-29       Impact factor: 9.623

Review 8.  Pediatric sepsis: challenges and adjunctive therapies.

Authors:  William Hanna; Hector R Wong
Journal:  Crit Care Clin       Date:  2013-01-03       Impact factor: 3.598

9.  Trauma patients' elevated tumor necrosis related apoptosis inducing ligand (TRAIL) contributes to increased T cell apoptosis.

Authors:  Gautam Bandyopadhyay; Paul E Bankey; Carol L Miller-Graziano
Journal:  Clin Immunol       Date:  2012-08-03       Impact factor: 3.969

10.  Elevated postinjury thrombospondin 1-CD47 triggering aids differentiation of patients' defective inflammatory CD1a+dendritic cells.

Authors:  Gautam Bandyopadhyay; Sanjukta Bandyopadhyay; Paul E Bankey; Carol L Miller-Graziano
Journal:  J Leukoc Biol       Date:  2014-07-07       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.